Make the profile of
StackWave, LLC yours.

Company description

StackWave is the creator of StackWave Affinity™, described as the most comprehensive software platform for biologics R&D. The platform is purpose-built for biologics research and development scientists, drawing on decades of domain experience to deliver an integrated solution that is ready to use from day one. StackWave Affinity serves a broad range of organizations — from CROs making customer deliveries and start-ups advancing toward IND, to established biopharma companies supporting multiple programs simultaneously.

Rather than relying on a collection of one-off tools, StackWave Affinity consolidates essential discovery capabilities into a single system at a single price, dramatically reducing software budgets while improving productivity across every team, from the lab bench to the C-suite.

Core Platform Capabilities

• Workflow Automation: Reduces repetitive tasks and human error by automating common workflows, data transformations, analyses, and hand-offs between teams.
• Single Data Repository: Provides one source of truth for all organizational data, enabling scientists to review results and identify patterns within teams, within projects, and across the entire organization.
• Support for Every Team: Designed to coordinate, support, and execute all scientist activities in one place, with seamless hand-off between teams throughout the R&D process.
• Advanced Reporting: Allows teams to design custom dashboards that monitor progress, identify bottlenecks, and support data-driven decision-making.

Key Product Highlights

• StackWave Affinity functions as a modern LIMS (Laboratory Information Management System) solution, and StackWave offers a free LIMS Buyer's Guide ebook to help organizations evaluate and level up their digital informatics capabilities.
• Recent platform updates include Affinity v15, which introduced titration and dose response experiment support, and Affinity v14, which added an integrated ELN (Electronic Lab Notebook) and support for nanobodies.
• The platform supports antibody and biologics lead identification, enabling teams to collect all data about potential therapeutics in one place and compare antibodies of interest to build confidence in leads.

Customers and Deployment

• StackWave Affinity is trusted by biologics R&D organizations including Scholar Rock, whose Director of R&D IT noted that the platform collects all data about potential therapeutics in one place and makes that data actionable.
• The platform is designed to scale with organizations at every stage — from early-stage start-ups to large, multi-program biopharma companies.
• StackWave provides a comprehensive Knowledge Base and ongoing product updates to ensure customers remain productive no matter how far they need to go or how much they need to grow.

StackWave Affinity™ represents an all-in-one biologics R&D platform that replaces fragmented toolsets with a unified, integrated environment — enabling every member of every team to work more confidently, efficiently, and cost-effectively.

AI-generated · replace with your own

Software attributed to StackWave, LLC

• StackWave AffinityView
• ELNView
• LabInspectorView

Edit all with premium access